Metin Yesiltepe
Affiliations: | Rutgers New Jersey Medical School |
Area:
Alzheimer's DiseaseGoogle:
"Metin Yesiltepe"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yesiltepe M, Yin T, Tambini M, et al. (2024) Correction: Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE. Cell Communication and Signaling : Ccs. 22: 619 |
| Yesiltepe M, Yin T, Tambini M, et al. (2024) Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE. Cell Communication and Signaling : Ccs. 22: 458 |
| Yin T, Yesiltepe M, D'Adamio L. (2024) Functional BRI2-TREM2 interactions in microglia: implications for Alzheimer's and related dementias. Embo Reports |
| Yesiltepe M, Yin T, D'Adamio L. (2023) Beyond amyloid: altered gene function in neurodegenerative diseases. Aging. 15: 9235-9237 |
| Tambini MD, Yin T, Yesiltepe M, et al. (2023) Aβ43 levels determine the onset of pathological amyloid deposition. The Journal of Biological Chemistry. 104868 |
| Yesiltepe M, Yin T, Tambini MD, et al. (2022) Late-long-term potentiation magnitude, but not Aβ levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease. Frontiers in Aging Neuroscience. 14: 1040576 |
| Yesiltepe M, Cimen B, Sara Y. (2022) Effects of chronic vagal nerve stimulation in the treatment of β-amyloid-induced neuropsychiatric symptoms. European Journal of Pharmacology. 931: 175179 |